Review of 127 studies links AI in drug research and care to bias, privacy and trust risks
By July 2026, a narrative review of 127 peer-reviewed studies from 2015-2026 examined how AI and ML are being used in pharmaceutical research and healthcare. The review found the technologies enable large-scale biomedical data analysis and data-driven decision-making while simultaneously introducing interconnected…
Journal of the American Pharmacists Association
ace
